One must admit admit it is somewhat strange that this was announced on the !0th and Dr. Wirths resignation was announced on the 11th. Just speculating but maybe Wirth felt he should be the sole advisor or was not in agreement with this appointment. Say what you want but leaving for personal reasons is an excuse. NVIV said no where in their release today thanking Dr. Wirth for his contribution or they are sorry to see him go or anything to that sort. This was not for personal reasons in my opinion. Problem is who knows if we will ever get the truth. InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma conditions, today announced that Arthur J. Coury, PhD, has joined the company as an advisor to the CEO.